{"id":"continue-cozaar","safety":{"commonSideEffects":[{"rate":"7-10","effect":"Dizziness"},{"rate":"3-5","effect":"Fatigue"},{"rate":"2-5","effect":"Hyperkalemia"},{"rate":"1-3","effect":"Cough"},{"rate":"5-7","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Losartan is an angiotensin II receptor antagonist (ARB) that selectively blocks the AT1 receptor, preventing angiotensin II from binding and triggering vasoconstriction and aldosterone release. This leads to decreased peripheral vascular resistance, lower blood pressure, and reduced sodium and water retention. It is commonly used as a first-line antihypertensive agent and for renal protection in diabetic patients.","oneSentence":"Cozaar (losartan) blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:37:02.993Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Diabetic nephropathy in patients with type 2 diabetes"},{"name":"Heart failure with reduced ejection fraction"}]},"trialDetails":[{"nctId":"NCT03900793","phase":"PHASE1","title":"Losartan + Sunitinib in Treatment of Osteosarcoma","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2019-08-26","conditions":"Osteosarcoma","enrollment":41},{"nctId":"NCT07265739","phase":"PHASE2","title":"Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-04","conditions":"Platinum Resistant Ovarian Cancer","enrollment":27},{"nctId":"NCT03563248","phase":"PHASE2","title":"Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-08-10","conditions":"Pancreatic Cancer","enrollment":168},{"nctId":"NCT05637853","phase":"PHASE4","title":"Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Göteborg University","startDate":"2022-10-22","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":60},{"nctId":"NCT04106856","phase":"PHASE1","title":"Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2019-08-08","conditions":"Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma","enrollment":22},{"nctId":"NCT02235909","phase":"PHASE3","title":"An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension","status":"COMPLETED","sponsor":"Arbor Pharmaceuticals, Inc.","startDate":"2015-03-30","conditions":"Hypertension","enrollment":377},{"nctId":"NCT03864042","phase":"PHASE1","title":"Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-01-02","conditions":"Advanced Solid Tumors, Metastatic Melanoma","enrollment":56},{"nctId":"NCT06333522","phase":"PHASE4","title":"Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2024-07-01","conditions":"Arthrofibrosis of Knee","enrollment":""},{"nctId":"NCT04335123","phase":"PHASE1","title":"Study of Open Label Losartan in COVID-19","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2020-04-04","conditions":"COVID-19","enrollment":34},{"nctId":"NCT01307033","phase":"PHASE3","title":"A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":278},{"nctId":"NCT00090259","phase":"PHASE3","title":"Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-12-19","conditions":"Heart Failure","enrollment":3834},{"nctId":"NCT02676466","phase":"PHASE2","title":"The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-04-26","conditions":"Inflammation","enrollment":289},{"nctId":"NCT04815902","phase":"PHASE1, PHASE2","title":"Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2021-05-18","conditions":"Osteoarthritis, Knee","enrollment":100},{"nctId":"NCT03878524","phase":"PHASE1","title":"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2020-04-01","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia","enrollment":2},{"nctId":"NCT05157464","phase":"PHASE4","title":"Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2023-09-01","conditions":"Arthrofibrosis","enrollment":""},{"nctId":"NCT05271448","phase":"NA","title":"Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-06-01","conditions":"Contrast-induced Nephropathy, Chronic Kidney Diseases, Ischemic Heart Disease","enrollment":600},{"nctId":"NCT01233635","phase":"PHASE4","title":"Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2005-11","conditions":"Atrial Fibrillation","enrollment":228},{"nctId":"NCT05064904","phase":"NA","title":"Multidiscipline Care for Acute Kidney Disease (AKD)","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2019-02-15","conditions":"Acute Kidney Injury","enrollment":300},{"nctId":"NCT04191681","phase":"PHASE4","title":"Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2019-11-08","conditions":"Stage D Heart Failure","enrollment":50},{"nctId":"NCT04340557","phase":"PHASE4","title":"Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection","status":"COMPLETED","sponsor":"Sharp HealthCare","startDate":"2020-03-27","conditions":"SARS-CoV Infection","enrollment":31},{"nctId":"NCT01852942","phase":"PHASE2","title":"Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2014-09","conditions":"HIV Infection, HIV Infections","enrollment":52},{"nctId":"NCT04349410","phase":"PHASE2, PHASE3","title":"The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol","status":"COMPLETED","sponsor":"The Camelot Foundation","startDate":"2020-04-11","conditions":"CoVid 19 Positive","enrollment":1800},{"nctId":"NCT00701428","phase":"PHASE4","title":"Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment","status":"COMPLETED","sponsor":"Skaraborg Hospital","startDate":"2008-06","conditions":"Hypertension, Sleep Apnea","enrollment":90},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT03953950","phase":"PHASE4","title":"Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2019-10","conditions":"End Stage Renal Disease, Peritoneal Dialysis","enrollment":84},{"nctId":"NCT00067990","phase":"PHASE4","title":"Angiotensin II Blockade for Chronic Allograft Nephropathy","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2002-12","conditions":"Kidney Disease, Proteinuria","enrollment":153},{"nctId":"NCT01281787","phase":"PHASE3","title":"PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer","status":"COMPLETED","sponsor":"European Institute of Oncology","startDate":"2008-04","conditions":"Lung Cancer, Atrial Fibrillation","enrollment":320},{"nctId":"NCT01667614","phase":"PHASE2","title":"Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2010-05","conditions":"Type 2 Diabetes Mellitus, Diabetic Nephropathy, Essential Hypertension","enrollment":136},{"nctId":"NCT01180413","phase":"PHASE4","title":"Intensive Vasodilator Therapy in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Aarhus University Hospital","startDate":"2010-12","conditions":"Essential Hypertension, High Blood Pressure","enrollment":48},{"nctId":"NCT01305850","phase":"PHASE4","title":"The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2010-07","conditions":"Peritoneal Membrane Failure","enrollment":100},{"nctId":"NCT01041963","phase":"PHASE4","title":"The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2009-06","conditions":"Continuous Ambulatory Peritoneal Dialysis","enrollment":90},{"nctId":"NCT01115426","phase":"PHASE4","title":"Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis","status":"COMPLETED","sponsor":"University Magna Graecia","startDate":"1997-01","conditions":"IGA Glomerulonephritis","enrollment":20},{"nctId":"NCT00617877","phase":"NA","title":"Antihypertensive Response to Losartan and Genetic Polymorphisms","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-03","conditions":"Hypertension","enrollment":800}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"continue cozaar","genericName":"continue cozaar","companyName":"University of Pittsburgh","companyId":"university-of-pittsburgh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cozaar (losartan) blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure. Used for Hypertension, Diabetic nephropathy in patients with type 2 diabetes, Heart failure with reduced ejection fraction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}